Peptech Biosciences Ltd. announced the successful acquisition of technology from the National Bureau of Agricultural Insect ...

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

A biomedical science expert has shared her advice on whether cooked rice can be safely reheated or not - and finally settled the debate once and for all ...

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01.

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

The following is a summary of “Factors predicting local or systemic side effects related to intravesical BCG (Bacillus Calmette-Guérin) therapy: a retrospective observational study,” published in the ...

WHILE investigating products in cultures of a strain of Bacillus subtilis, we obtained a crystalline substance which sublimed very easily even at ordinary temperature and had the characteristic ...

Delavie Sciences introduces microbiome-friendly Aeonia Sculpting Cream: a breakthrough in age-defying skincare ...

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.